Who are FOL-005's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ISV-403, EM-100.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fol-005.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

FOL-005 — Competitive Intelligence Brief

FOL-005 (FOL-005) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Wnt/β-catenin pathway activator. Area: Dermatology.

phase 2 Wnt/β-catenin pathway activator Wnt/β-catenin signaling pathway Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

FOL-005 (FOL-005) — Follicum AB. FOL-005 is a Wnt/β-catenin signaling activator designed to stimulate hair follicle growth and treat hair loss.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
FOL-005 TARGET	FOL-005	Follicum AB	phase 2	Wnt/β-catenin pathway activator	Wnt/β-catenin signaling pathway
ISV-403	ISV-403	Bausch & Lomb Incorporated	phase 3	Wnt/β-catenin pathway inhibitor	Wnt/β-catenin signaling pathway
EM-100	EM-100	Bausch & Lomb Incorporated	phase 3	Wnt/β-catenin pathway inhibitor	Wnt/β-catenin signaling pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Wnt/β-catenin pathway activator class)

Follicum AB · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). FOL-005 — Competitive Intelligence Brief. https://druglandscape.com/ci/fol-005. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab